Hipercalcemia causada por inyección subcutánea con metacrilato

  • Francisco Rodolfo Spivacow Instituto de Diagnóstico e Investigaciones Metabólicas, Buenos Aires


Donovan PJ, Sundac L, Pretorius CJ, D’Emden MC, McLeod DS. Calcitriol-mediated hypercalcemia: causes and course in 101 patients. J Clin Endocrinol Metab. 2013;98(10):4023-9.

Garabédian M, Jacqz E, Guillozo H, Grimberg R, Guillot M, Gagnadoux MF, et al. Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies. N Engl J Med. 1985;312(15):948-52.

Sturm LP, Cooter RD, Mutimer KL, Graham JC, Maddern GJ. A systematic review of dermal fillers for age-related lines and wrinkles. ANZ J Surg. 2011;81(1-2):9-17.

Oppenlander ME, Bina R, Snyder LA, Dickman CA. Intravertebral polymethylmethacrylate augmentation of anterior cervical discectomy fusion and plating in the setting of osteoporosis. J Spinal Disord Tech. 2014;27(3):185-8.

Jo JY, Kang SH, Park SW. Modified polymethylmethacrylate cervical plate and screw augmentation technique for intraoperative screw loosening. J Spinal Disord Tech. 2012;25(4):235-9.

Jaeblon T. Polymethylmethacrylate: properties and contemporary uses in orthopaedics. J Am Acad Orthop Surg. 2010;18(5):297-305.

Webb JC, Spencer RF. The role of polymethylmethacrylate bone cement in modern orthopaedic surgery. J Bone Joint Surg Br. 2007;89(7):851-7.

Lee YB, Song EJ, Kim SS, Kim JW, Yu DS. Safety and efficacy of a novel injectable filler in the treatment of nasolabial folds: polymethylmethacrylate and cross-linked dextran in hydroxypropyl methylcellulose. J Cosmet Laser Ther. 2014;16(4):185-90.

Lemperle G, Sadick NS, Knapp TR, Lemperle SM. ArteFill permanent injectable for soft tissue augmentation: II. Indications and applications. Aesthetic Plast Surg. 2010;34(3):273-86.

Medeiros CC, Cherubini K, Salum FG, De Figueiredo MA. Complications after polymethylmethacrylate (PMMA) injections in the face: a literature review. Gerodontology. 2014;31(4):245-50.

Salles AG, Lotierzo PH, Gemperli R, Besteiro JM, Ishida LC, Gimenez RP, et al. Complications after polymethylmethacrylate injections: report of 32 cases. Plast Reconstr Surg. 2008;121(5):1811-20.

Wu W, Chayavichitsilp P, Hata T. Extremely delayed granulomatous reaction to soft-tissue injectables (polymethyl methacrylate). J Am Acad Dermatol. 2012;67(5):e206-7.

Negri AL, Rosa Diez G, Del Valle E, Piulats E, Greloni G, Quevedo A, et al. Hypercalcemia secondary to granulomatous disease caused by the injection of methacrylate: a case series. Clin Cases Miner Bone Metab. 2014;11(1):44-8.

Hewison M, Burke F, Evans KN, Lammas DA, Sansom DM, Liu P, et al. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol. 2007;103(3-5):316-21.

Lewiecki EM. Clinical use of denosumab for the treatment for postmenopausal osteoporosis. Curr Med Res Opin. 2010;26(12):2807-12.

Cómo citar
Spivacow FR. Hipercalcemia causada por inyección subcutánea con metacrilato. Rev Nefrol Dial Traspl. [Internet]. 1 de diciembre de 2016 [citado 18 de julio de 2024];36(4):235-40. Disponible en: http://revistarenal.org.ar/index.php/rndt/article/view/93